T1	Participants 64 120	paired biopsy study in postmenopausal osteoporotic women
T2	Participants 625 645	ten paired biopsies,
T3	Participants 501 612	paired biopsies of osteoporotic women treated with either strontium ranelate (SrRan) or a placebo for 36 months
